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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYMesenchymal stromal cells have shown clinical promise; however, variations in treatment responses are an ongoing concern. We previ-
ously demonstrated that MSCs are functionally stunned after thawing. Here, we investigated whether this cryopreservation/thawing
defect also impacts the postinfusion biodistribution properties of MSCs. Under both static and physiologic flow, compared with live
MSCs in active culture, MSCs thawed from cryopreservation bound poorly to fibronectin (40% reduction) and human endothelial cells
(80% reduction), respectively. This reduction correlated with a reduced cytoskeletal F-actin content in post-thawMSCs (60% reduction).
In vivo, live human MSCs could be detected in murine lung tissues for up to 24 hr, whereas thawed MSCs were undetectable. Similarly,
live MSCs whose actin cytoskeleton was chemically disrupted were undetectable at 24 hr postinfusion. Our data suggest that post-thaw
cryopreserved MSCs are distinct from live MSCs. This distinction could significantly affect the utility of MSCs as a cellular therapeutic.INTRODUCTION
Mesenchymal stromal cells (MSCs) are a promising cellular
therapeutic for numerous disorders because of their anti-in-
flammatory/regenerative properties and the fact that they
are readily expandable ex vivo (Copland and Galipeau,
2011). However, discrepancies in the therapeutic effective-
ness of these cells as determined in phase II/III trials have
called into question their therapeutic utility (Galipeau,
2013). A common practice in many MSC immunotherapy
trials is to expand MSCs ex vivo and then cryogenically
bank them until needed. The MSCs are then thawed and
administered within a couple of hours to the patient. Until
recently, the assumption was that viable post-thaw MSCs
have physiological features comparable to those of their
noncryopreserved counterparts. We have found that this
premise may be flawed. Previously, we demonstrated that
cryopreserved MSCs (cryo MSCs) have a blunted in-
doleamine 2,3-dioxygenase (IDO) response immediately
post-thaw, which significantly reduced their immunomod-
ulatory activity (Franc¸ois et al., 2012). In support of this
idea are experimental data showing that when renal
allograft recipients are treated with the IDO inhibitor
1-methyl-tryptophan or with IDO-deficient MSCs, toler-
ance is not established (Ge et al., 2010). Thus, MSCs must
retain their capacity to make IDO to evoke an immunosup-
pressive effect.60 Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The AuthorsFor MSCs to have an immunosuppressive effect, they
must not only actively respond to inflammatory cues but
also persist/engraft within the body (Huang et al., 2010;
Richardson et al., 2013; Sarkar et al., 2011). Systemic infu-
sion of MSCs in nonhuman primates demonstrated that
MSCs can take up residence in many tissues (Devine
et al., 2003), but upon sensing an injury signal, MSCs will
home to areas of inflammation (Li et al., 2002). Whether
the means by which MSCs are prepared for administration
impacts their homing/engraftment potential has not been
rigorously evaluated. However, Castelo-Branco et al. (2012)
demonstrated that transfused cryoMSCs could notmigrate
to an inflamed colon and had no beneficial effect in a 2,4,6-
trinitrobenzenesulfonic acid (TNBS)-induced colitismodel.
This suggests that cryo MSCs may have an engraftment
defect. In our efforts to optimize the therapeutic utility of
MSCs, we compared the in vitro and in vivo binding/
engraftment potential of human MSCs (hMSCs) thawed
from cryopreservation with that of MSCs in active culture.RESULTS
Cryo hMSCs Show Attenuated Binding in Static and
Flow Conditions In Vitro
Previously, we demonstrated that cryo MSCs are function-
ally stunned immediately after thawing (Franc¸ois et al.,
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preservation impacts the functional properties ofMSCs, we
compared the binding potential of cells thawed from cryo-
preservation (cryo MSCs) with that of cells harvested from
active culture (live MSCs) in vitro. Based on trypan blue
exclusion of early passage (p3–5) MSCs from five different
donors, viability was 92% ± 2.51% when they were in
active culture; however, immediately post-thaw, there
was a small but significant reduction in viability to 87% ±
2.76% (Figure 1A). This reduction in viability post-thaw
was even more apparent when we utilized Annexin V/pro-
pidium iodide (PI) staining (Figure 1B), which can better
discriminate between cells that are live (Annexin V/PI)
or in early apoptosis (Annexin V+/PI), mid–late apoptosis
(Annexin V+/PI+), or necrosis (Annexin V/PI+). In a
paired comparison of five unique MSC donors, we noted
that the percentage ofMSCs in apoptosis was always higher
in the cryo MSCs compared with their paired live MSC
counterparts (Figure 1C). Thus, MSC viability was reduced
immediately after thawing; however, the degree of reduc-
tion varied substantially depending on the assay em-
ployed. Because of the discrepancy between our trypan
blue and Annexin V/PI staining results, we chose to rely
on trypan blue exclusion in the remaining experiments
to normalize the total number of viable cells for compari-
son of cryo and live MSCs. The rationale for this was based
on two lines of thought: first, Annexin V/PI staining can
produce false-positive signals (Rieger et al., 2010), and sec-
ond, trypan blue is the most commonly used method to
evaluate MSC viability clinically (see Discussion for more
detailed comments). Next, we investigated whether MSC-
integrin-based binding to extracellular matrix was altered
post-thaw. Under static conditions, viable PHK26-labeled
cryo or live MSCs were seeded onto fibronectin-coated
plates at 5,000 cells/cm2 and allowed to attach for 2 hr at
37C in a 5%CO2 incubator. Qualitatively, there was a clear
reduction in the number of bound cryo MSCs compared
with live MSCs (Figure 1D). Quantitatively, using both
standard hemocytometer cell counting (data not shown)
and the flow-cytometricmethod described in Experimental
Procedures, we found that cryo MSCs had a significant
reduction in binding capacity to fibronectin relative to
live MSCs (live 100.00% ± 5.61% versus cryo 60.06% ±
5.64; Figure 1E). This binding defect was even more pro-
nounced when cryo MSCs were exposed to vascular flow
conditions. Specifically, by utilizing a three-dimensional
endothelialized fluidic system (Tsai et al., 2013; Figure 1F),
we infused cryo and live MSCs at a rate equivalent to 2
dynes/cm2 into the microfluidic device for 1 hr and
observed a profound difference in the ability of Cyro
MSCs to bind to endothelial cells compared with live
MSCs (live MSCs 6.3 ± 0.9/channel versus cryo MSCs
1.3 ± 0.3/channel; Figure 1G).Cryo hMSCs Show Attenuated Engraftment in the
Lungs In Vivo
Because no in vitro system can fully recapitulate the com-
plexities of in vivo cell adhesion, migration, and homing,
we next evaluated the engraftment potential of hMSCs in
C57BL/B6 mice. In order to track hMSCs in vivo, we
infused hMSCs from a male donor into female mice and
measured the relative engraftment of MSCs by measuring
the male Y-chromosome SRY gene by real-time PCR (Fig-
ure S1A available online). By performing in vitro mixing
experiments using combinations of male hMSCs with
female mouse splenocytes, we established a highly sensi-
tive human SRY detection limit of one male hMSC in 200
mouse cells (0.5% frequency; Figure S1B). Feasibility exper-
iments demonstrated that intravenous infusion of male
hMSCs into female mice resulted in SRY gene detection
exclusively within the lungs as early as 5 min postinfusion
(Figure S1C). Biodistribution and kinetics experiments
using multiple unique hMSC populations infused into
mice demonstrated that at 24 hr, hMSCs could be readily
detected within the lungs, but by 3 days the hMSCs could
no longer be identified in the lungs (Figure 2A) or in any
other organs tested (Figure S2). Based on these data, we
selectedMSC engraftment in the lung at 24 hr postinfusion
as a surrogate to compare and contrast the in vivo binding
potential of cryoMSCs immediately post-thawwith that of
live MSCs. Consistent with our in vitro data, we found that
cryo MSCs, from two separate donors, had significantly
reduced lung engraftment as compared with their live
MSC counterparts (cycle of threshold [CT]1cryo = 0.030 ±
0.0020;CT1live = 0.034 ± 0.0032;CT
1
NoMSC = 0.029 ±
0.0021; Figure 2B). To validate our SRY gene readout, we
reproduced these findings using a human-specific genomic
DNA (gDNA) primer set and showed that there was again a
significant difference in hMSC engraftment between live
and cryo MSCs (CT1cryo = 0.029 ± 0.0022;CT
1
live =
0.033 ± 0.0020;CT1NoMSC = 0.028 ± 0.0016), whereas
there was no difference in signal when mouse lung gDNA
was tested using a mouse-specific gDNA primer set (Figures
2C and 2D).
Dead Cells in the Infusion Mixture Neither Bind Nor
Influence Lung Homing of Live MSCs In Vivo
Both our trypan blue and Annexin V/PI viability data
suggested that an increase in the number of dead and/or
dying cells might explain some of our data; however, it
is unknown whether dead cells can modulate the engraft-
ment of live cells. To resolve this issue, we infused amixture
of live and dead hMSCs into the animals. hMSCs from
a male individual were heat killed and mixed with
live MSCs from a female MSC donor at a ratio of 1:1 (Fig-
ure 3A). The infusion mixture was then subjected to SRY
and total human gDNA real-time PCR to ensure that SRYStem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authors 61
Figure 1. Cryo hMSCs Show Attenuated Binding In Vitro under Both Static and Flow Conditions
(A) Cumulative trypan blue cell viability counts of cryo versus live MSCs from five independent experiments using five unique MSC donors.
(B) MSCs thawed from cryopreservation (cryo MSCs) or in active culture (live MSCs) were subjected to Annexin V/PI staining and acquired
by flow cytometry. The top panel shows the forward scatter/side scatter profile and the bottom panel shows Annexin V/PI staining
representations of cryo and live MSC populations.
(C) Pie diagram showing the relative frequencies of Annexin V/PI, Annexin V+/PI+, and Annexin V+/PI populations, as well as
cumulative Annexin V/PI, Annexin V+/PI+, and Annexin V+/PI frequencies from five independent experiments using five unique
donors.
(D and E) Cryo and live MSCs were labeled with the fluorescent dye PKH26 and seeded onto plates coated with fibronectin. Two hours later,
unbound cells were washed off the plates and cell adherence was measured (D) qualitatively by microscopy and (E) quantitatively by flow
cytometry.
(F) Macroscopic view of the microfluidic flow chamber.
(G) Endothelial cell-coated microchannels were infused (2 dynes/cm2) with fluorescently labeled cryo and live MSCs. One hour after
infusion, the bound MSCs were measured by fluorescence microscopy. For trypan blue and Annexin V/PI, individual viability numbers are
shown; relative cell attachment is shown as cumulative mean ± SD based on three independent experiments using three unique MSC
donors. A p value < 0.05 was considered statistically significant based on two-tailed t tests.
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Figure 2. Cryo hMSCs Show Attenuated Engraftment In Vivo
(A) Human male MSCs (1 3 106) were injected intravenously into
female C57BL/B6 mice through the tail vein. The animals were
sacrificed at the indicated time points and the lungs were collected
for gDNA extraction and SRY real-time PCR.
(B–D) Viable cryo or live hMSCs (13 106) were injected into the tail
vein of C57BL/B6 mice. At 24 hr postinfusion, the animals were
sacrificed and the lungs were excised to extract total gDNA for real-
time PCR amplification of (B) human SRY, (C) human gDNA, and (D)
mouse gDNA. CT1 values are shown on the y axis. Individual CT1
values and the cumulative mean ± SD from two to three indepen-
dent experiments (n = 5 or 6 animals per group) performed with two
unique MSC donors are shown. A p value < 0.05 was considered
statistically significant based on one-way ANOVA and Tukey’s
multiple comparison test.
See also Figures S1 and S2.
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infused with both live (female) and dead (male) or live
(female) and live (male) MSC mixtures were sacrificed
24 hr postinjection. Our results clearly demonstrate
that dead cells do not engraft in the lungs (Figures 3B
and 3C; SRYCT1female-live male-live = 0.031 ± 0.0021;
SRYCT1female-live male-dead = 0.028 ± 0.00054) and do not
alter the engraftment of live cells when they are part of
the infusion mixture (SRYCT1male-live_female-live = 0.031 ±
0.0021; SRYCT1male-live_female-dead = 0.031 ± 0.0011; Fig-
ures 3D and 3E).
Cryopreservation Does Not Alter Adhesion Molecule
Expression on MSCs
It was previously demonstrated that hematopoietic stem
cells (HSCs) shed L-selectin (CD62L) upon thawing aftercryopreservation (De Boer et al., 1998; Koenigsmann
et al., 1998). Consequently, we investigated whether the
attenuated binding potential of MSCs could be explained
by changes in the surface expression of adhesionmolecules
on MSCs after cryopreservation. Using flow cytometry, we
evaluated the expression level of various cell-surface mole-
cules, including tetraspanin (CD63), Integrin alpha V
(CD51), MHC class I (HLA-ABC), Integrin beta 1(CD29), In-
tegrin alpha 4 (CD49d), Integrin alpha IIb (CD41), ICAM 1
(CD54), Integrin beta 3 (CD61), and Integrin alpha 5
(CD49e). Compared with their isotype controls (Figure 4A,
gray histograms), MSCs showed surface expression (Fig-
ure 4A, open histograms) of CD63, CD51, HLA-ABC,
CD29, CD49d, CD61, and CD49e, but did not show strong
expression of CD41 or CD54 (Figure 1A). For the markers
evaluated, there were no obvious differences in the cell-
surface expression patterns of paired live and cryo MSC
donors (n = 2), suggesting that cryoMSCs do not shed their
adhesionmolecules during the cryopreservation and thaw-
ing process (Figures 4A and 4B). Consistent with these data,
there was no difference in the surface expression of the
SDF-1 chemokine receptor CXCR4 between live and cryo
MSCs (data not shown).
Cryo MSCs Exhibit Metabolic Activities Similar to
Those of Live MSCs
An alternative explanation for the reduced binding of cryo
MSCs could relate to their metabolic fitness. Previously, the
ability of a cell to evoke a calcium influx was shown to
mediate monocyte adhesion to endothelial cells (Himi
et al., 2012); therefore, we measured the ability of cryo
and live MSCs to take up extracellular calcium. Incubating
cryo and live MSCs with a fluorescent Ca+2 indicator
demonstrated no difference between cryo and live MSCs
with regard to their kinetic uptake of the fluorescent Ca+2
indicator (Figures 5A and 5B). Similarly, whenwemeasured
the metabolic activity of live and cryoMSCs based on their
ability to reduce the viability dye PrestoBlue, we found no
difference between the two groups regardless of seeding
density (% PrestoBlue reduction: live MSCs 73% ± 5%
and cryo MSCs 78% ± 7% at the highest seeding density;
Figure 5C).
Cryopreservation Disrupts Actin Polymerization and
Limits the Engraftment of MSCs in Vivo
Because there were no obvious cell-surface or metabolic
defects that could explain the reduced binding of cryo
MSCs, we evaluated the ability of MSCs to form F-actin,
as cryopreservation was previously shown to alter the actin
cytoskeleton in both fibroblasts and MSCs (Ragoonanan
et al., 2010; Xu et al., 2012). Both cryo and live MSCs
were seeded onto fibronectin-coated plates for 2 hr. Un-
bound cells were then washed off and attached cells wereStem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authors 63
Figure 3. Dead MSCs in the Infusion
Mixture Do Not Engraft In Vivo and Do
Not Influence Engraftment of Live MSCs
In Vivo
(A) 7AAD viability staining of MSCs that
were live, heat killed, or a combination of
the two.
(B and C) Male MSCs (1 3 106) live or heat
killed (dead), were mixed with live MSCs
derived from a female donor at a ratio of 1:1
(0.5 3 106 each) and then injected intra-
venously into C57BL/B6 mice via the tail
vein. At 24 hr postinfusion, the animals
were sacrificed and the lungs were excised
to extract total gDNA for real-time PCR
amplification of (B) SRY and (C) human
gDNA.
(D and E) Female MSCs (13 106) live or heat
killed (dead), were mixed with live MSCs
derived from a male donor at a ratio of 1:1
(0.5 3 106 each) and then injected intra-
venously into C57BL/B6 mice via the tail
vein. At 24 hr postinfusion, the animals
were sacrificed and the lungs were excised
to extract total gDNA for real-time PCR
amplification of (D) SRY and (E) human
gDNA. Individual CT1 values and the cu-
mulative mean ± SD from two independent
experiments (n = 4–5 animals per group)
performed with male and female MSC donors
are shown. A p value < 0.05 was considered
statistically significant based on two-tailed
t tests.
See also Figure S3.
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phalloidin to visualize F-actin microscopically. Compared
with live MSCs, the abundance and organization of F-actin
in cryo MSCs was qualitatively different (Figure 6A). On a
per cell basis, quantitatively, F-actin content was signifi-
cantly lower in Cyro MSCs than in their live MSC counter-
parts (Figure 6B). These data suggested that defective
F-actin polymerization may explain the reduced binding
capacity of cryo MSCs. Therefore, we tested whether
disruption of F-actin could influence the engraftment
potential of MSCs in vivo. We chemically disrupted F-actin
of live MSCs with 2 mM of Cytochalasin D for 2 hr prior to
infusion. Consistent with prior reports (Yourek et al.,
2007), a 2 hr incubationwith 2 mMof Cytochalasin D effec-
tively disrupted F-actin (Figure 6C), but did not cause
significant cell death (Figures 6D and S4). Intravenous infu-
sion of 1 3 106 control (DMSO-treated) or Cytochalasin
D-treated MSCs into C57BL/B6 animals demonstrated64 Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authorsthat at 24 hr postinfusion, animals that were infused
with Cytochalasin D-treated MSCs had significantly fewer
MSCs in the lung than the control live MSCs (CT1live =
0.033 ± 0.0022; CT1CytochalasinD = 0.031 ± 0.0025; Fig-
ure 6E), whereas the loading control mouse gDNA CT1
values were similar (Figure 6F).
Culture Rescue of MSCs Post-Thaw Restores Their
In Vivo Biodistribution Potential
Previously, we demonstrated that the immunosuppressive
functionality of MSCs could be restored post-thaw by a
short culture recovery period (Franc¸ois et al., 2012). Here,
in a final investigation, we determined whether a similar
culture recovery could restoreMSCs’ engraftment potential
post-thaw. Using two separated hMSC donors, we injected
C57BL/B6 mice via the tail vein with 1 3 106 MSCs that
were live (cultured for >7 days), cryo (thawed the day of
infusion), or Recovered (48 hr culture post-thaw). At
Figure 4. Cryopreservation Does Not
Alter the Expression of Adhesion Mole-
cules on MSCs
(A) Flow-cytometric analysis of the adhe-
sion molecules tetraspanin (CD63), Integrin
alpha V (CD51), MHC class I (HLA-ABC),
Integrin beta 1 (CD29), Integrin alpha 4
(CD49d), Integrin alpha IIb (CD41), ICAM1
(CD54), Integrin beta 3 (CD61), and In-
tegrin alpha 5 (CD49e) on live or cryo MSCs.
Open histograms represent the adhesion
molecule expression and gray histograms
represent the appropriate isotype control.
(B) Cumulative mean fluorescent intensity
(MFI) of adhesion marker expression as the
average mean ± SD from two independent
experiments using two unique MSC donors.
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F-Actin Depolymerization in Thawed MSCs24 hr postinfusion, the lungs were excised and human
gDNA real-time PCR was performed to quantify the
engraftment of MSCs. Our results clearly demonstrate
that a 48 hr culture recovery corrects the immediate post-
thaw in vivo binding defect we observe in hMSCs
(CT1cryo = 0.028 ± 0.00066; CT
1
48hr = 0.030 ± 0.0012;
CT1live = 0.030 ± 0.00083; CT-1control = 0.027+0.00082;
Figures 7A and 7B).DISCUSSION
Large-scale expansion and cryopreservation of MSCs is an
attractive option from a clinical delivery perspective.Manufacturing large lots of a therapeutic provides a degree
of consistency, economy of scale, and reduced regulatory
burden with regard to lot testing and release criteria.
Furthermore, the ability to thaw a product and infuse it
within a short time frame provides an approach that is
convenient and requires neither specialized equipment
nor extensive personnel training to perform. However, un-
less the prefreeze functionality of the product is preserved
post-thaw, the cost savings and convenience benefits will
be outweighed by the prospect of reduced therapeutic
potency. In the present study, we expand on our previous
observations that cryopreservation attenuates the immu-
nosuppressive capacity of MSCs by demonstrating thatStem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authors 65
Figure 5. Cryo MSCs Exhibit Metabolic
Activities Similar to Those of Live MSCs
(A) Relative fluorescence of MSCs incubated
with the calcium influx indicator Fluo-NW at
the indicated time points as measured by
flow cytometry.
(B) Fluo-NW MFI between cryo and live MSCs
at the indicated time points.
(C) Comparison of PrestoBlue dye (In-
vitrogen) reduction of cryo and live MSCs at
varying seeding densities. Representative
results from two independent experiments
performed on two unique MSC donors are
shown.
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potential immediately post-thaw.
The homing/engraftment of MSCs is the process by
which cells migrate, engraft, and exert local functional
effects. Homing involves a cascade of events initiated by
shear-resistant adhesive interactions between flowing cells
and the target endothelium or extracellular matrix. This
process is mediated by adhesion receptors expressed on
circulating cells that engage relevant coreceptors, resulting
in cell tethering, rolling, and firm adherence (Sackstein,
2005). Similarly to induction of IDO in MSCs, we demon-
strate that homing/engraftment ofMSCs is an ‘‘active’’ pro-
cess that requires cells that are metabolically (i.e., viable)
and functionally fit, as deadMSCs or those with a disrupted
actin cytoskeleton do not engraft. We demonstrate that
immediately after thawing, cryo MSCs have a reduced
capacity to bind to both extracellular matrix molecules
(i.e., fibronectin) and endothelial cells, and these binding
defects can be reproduced in vivo. Consistent with our
data, Castelo-Branco et al. (2012) showed that cryo MSCs
are incapable of homing to the inflamed colon in a murine
model of colitis, and Hattori et al. (2001) showed that HSCs
also have a migratory defect post-thaw. Thus, we propose
that the process of cryopreservation and thawing exerts a
generic negative effect on cells with regard to their migra-
tory/homing properties.
Cryoinjury is a significant problem in many primary cell
types (Durkut et al., 2013; Fortunato et al., 2013) and is
likely associated with both generic and cell-specific effects.
Within the mesenchymal lineage, both hMSCs (Franc¸ois66 Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authorset al., 2012) and human primary fibroblasts (Liu et al.,
2000) undergo a biochemical ‘‘heat-shock stress response’’
when thawed from cryopreservation, which not only
serves to protect the cells from death (Beere, 2005; Yenari
et al., 2005) but can also result in protein synthesis inhibi-
tion (Cuesta et al., 2000; Doerwald et al., 2003).
Conversely, although both HSCs andMSCs have a reduced
binding potential post-thaw, mechanistically the defect
appears to be cell-type dependent. For HSCs, the primary
defect appears to be due to shedding of L-selectin from
the membrane (De Boer et al., 1998; Koenigsmann et al.,
1998) and is due primarily to DMSO exposure rather
than the freezing process. Selectins comprise a family of
three members (E-, P-, and L-selectin), are differentially ex-
pressed by leukocytes and endothelial cells, and are
involved in the early steps of leukocyte extravasation.
There is no evidence from the literature that MSCs possess
selectins (Ru¨ster et al., 2006); thus, shedding of selectin is
unlikely to explain our result. On the other hand, MSCs do
express numerous cell adhesion molecules, including
VLA4 (CD49d and CD29 integrins) (De Ugarte et al.,
2003), that can interact with VCAM-1 on endothelial cells.
As such, we investigated whether receptor shedding of
nonselectin adhesion receptors might explain the defect
we observed. Our data suggested that receptor shedding
is unlikely to be the putative cause for reduced MSC bind-
ing immediately post-thaw. Furthermore, we ruled out
viability, calcium influx, and metabolism as possible ex-
planations. Thus, the homing defect in MSCs that occurs
immediately after thawing is not only different from
Figure 6. Cryo MSCs Show Defective
F-Actin Polymerization Compared with
Live MSCs
(A) MSCs thawed from cryopreservation
(cryo MSCs) or MSCs trypsinized out of the
flasks from the incubator (live MSCs) were
seeded onto fibronectin-coated glass cov-
erslips. Two hours after attachment, cells
were fixed with formalin and stained for
F-actin (red, phalloidin conjugated with
Alexa 555) and nuclei (blue, DAPI). Images
were taken using a Zeiss microscope at 203
magnification.
(B) Percentage reduction of F-actin MFI in
cryo MSCs compared with live MSCs.
(C) Nontreated MSCs and MSCs treated with
Cytochalasin D (2 mM) for 2 hr were seeded
onto fibronectin-coated glass coverslips
and then stained for F-actin (red) and DAPI
(blue).
(D) Cytochalasin D-treated MSCs and non-
treated MSCs were trypsinized, subjected to
Annexin V/PI staining, and analyzed by
flow cytometry.
(E and F) MSCs (1 3 106) with or without
Cytochalasin D treatment were injected
intravenously into C57BL/B6 mice via the
tail vein. At 24 hr postinfusion, the animals
were sacrificed and the lungs were excised
to extract total gDNA for real-time PCR
amplification of (E) human gDNA and (F)
mouse gDNA. In vitro F-actin quantification
is shown as the cumulative mean ± SD
based on the averaged signal of at least five
unique fields from two independent exper-
iments with two separate MSCs donors.
In vivo individual CT1 values and the
cumulative mean ± SD from three inde-
pendent experiments (n = 4–5 animals per group) performed with two unique MSC donors are shown. A p value < 0.05 was considered
statistically significant based on two-tailed t tests.
See also Figure S4.
Stem Cell Reports
F-Actin Depolymerization in Thawed MSCsthat seen in HSCs but is also independent of basal
metabolism.
Although the mechanical properties of adhesive attach-
ments are usually attributed to the ligand-receptor interac-
tion, the strength and survival of cell attachment depend
heavily on molecular connections below the plasma mem-
brane surface (Evans and Calderwood, 2007). In particular,
the interactions of the cytoplasmic integrin b tails with
intracellular cytoskeletal and signaling proteins figure
prominently in the regulation of integrin activation (Evans
and Calderwood, 2007). Furthermore, efficient actin poly-
merization organization and remodeling are critically
important for stabilizing integrin ligand interactions,
which allows cells to resist detachment under conditionsof flow (Rullo et al., 2012). Recently, Xu et al. (2012) evalu-
ated the effect of cooling rates on the recovery of MSCs
from cryopreservation and demonstrated that immediately
after thawing, the F-actin component of the cytoskeletons
was disrupted. They further demonstrated that the critical
process that led to the changes in F-actin morphology
and distribution was not the addition/removal of the cryo-
preservative (i.e., DMSO), but rather the freezing process
itself, and that slower cooling rates of 5C/min and 10C/
min resulted in greater disruption (Xu et al., 2012). In
another study, Ragoonanan et al. (2010) demonstrated
that post-thaw cryo MSCs show abnormal actin
morphology as well as changes in intracellular pH and
mitochondrial aggregation. This prompted us toStem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authors 67
Figure 7. Culture Rescue of MSCs after Thawing Restores Their
In Vivo Biodistribution Potential
(A and B) Thawed (cryo), 48 hr culture-rescued (Recovered 48 hr),
or 7 day cultured (live) MSCs (13 106) were injected intravenously
into C57BL/B6 mice via the tail vein. At 24 hr postinfusion, the
animals were sacrificed and the lungs were excised to extract total
gDNA for real-time PCR amplification of (A) human gDNA and (B)
mouse gDNA. Individual CT1 values and the cumulative mean ± SD
from two independent experiments (n = 5 and 7 animals per group,
respectively) performed with two unique MSC donors are shown. A
p value < 0.05 was considered statistically significant based on one-
way ANOVA and Tukey’s multiple comparison tests.
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F-Actin Depolymerization in Thawed MSCsinvestigate the F-actin polymerization capabilities of MSCs
in our system. In agreement with the above reports, we
found that (1) immediately after thawing, cryo MSCs had
a significantly reduced capacity to polymerize F-actin
in vitro, and (2) when the F-actin cytoskeleton of cultured
live MSCs was chemically disrupted, they lost their capac-
ity to engraft in vivo. Thus, the ability of MSCs to rapidly
remodel their cytoskeleton is a significant contributor to
the homing/engraftment defect we observed. Other
possible contributors to the MSC binding defect we
observed include alterations in integrin confirmation or
clustering that could impact binding affinity or avidity,
respectively, as well as alterations in the formation of
macromolecular adhesion complexes that could impact
signal transduction. However, these were not evaluated in
this study. In future studies, understanding how cryopres-
ervation and thawing affects the intra- and extracellular
binding machinery of MSCs, and developing strategies to
mitigate these binding defects may help to improve the
therapeutic utility of MSCs and minimize potential safety
issues.
In addition to demonstrating how the cryopreservation
and thawing process impacts the binding characteristics
of MSCs, we observed that viability can vary substantially
depending on the assay employed. In this work, we utilized
several methods to determine cell viability, which yielded
different results. As shown in Figure 1, we compared the
results from trypan blue exclusion and Annexin V/PI68 Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authorsstaining, and in both assays we noted that post-thaw
MSCs had reduced viability compared with their live coun-
terparts; however, the values obtained with trypan blue
and Annexin V/PI were substantially different. We attri-
bute these differences to the different sensitivities and spec-
ificities of the respective assays. Trypan blue exclusion is by
far the most commonly used method to assess viability
because it is easily performed, generally has a low false-
positive rate, and requires only a hemocytometer and
microscope. Unfortunately, trypan blue is not particularly
sensitive and can be subject to interoperator variability
and yield ambiguous or conflicting results. Conversely,
Annexin V/PI staining is very sensitive and can discrimi-
nate between cells at various stages of the cell-death spec-
trum. However, the Annexin V/PI assay can also produce
significant false-positive signals. Specifically, PI has the po-
tential to bind to RNA in the cytosol (Rieger et al., 2010),
and there are multiple examples of cells that are Annexin
V positive do not actually undergo apoptosis because the
translocation of phosphatidylserine to the cell surface is a
reversible process (Kenis et al., 2010; van den Eijnde
et al., 2001). Furthermore, because DMSO is known to
induce transient pores (Gurtovenko and Anwar, 2007; He
et al., 2012; Notman et al., 2006) it is possible that a signif-
icant, nonspecific influx of bothAnnexinVand PI occurred
in our MSCs post-thaw. Given the false-positive potential
of Annexin V/PI, we chose to normalize our seeding and
infusion experiments based on trypan blue viability.
Because we used trypan blue versus Annexin V/PI to
normalize for live cells, we feel confident that viability dif-
ferences between the two methods did not unduly influ-
ence the data or our interpretation. This assertion is based
on the data generated for Figure 3, which show that even
when 50% dead cells were infused, we could still reliably
detect live cells at 24 hr postinfusion.
To date, the prevailing concept has been that viability
and functionality are directly linked; however, our findings
argue that viability does not equate to functionality. To
help mitigate the impact of cryopreservation on MSCs,
several studies have aimed to enhance the quality of the
infused product by improving viability post-thaw using
various cryopreservation/thawing techniques (Haack-Sør-
ensen and Kastrup, 2011; Lee et al., 2012; Li et al., 2013;
Pravdyuk et al., 2013). Although they achieved some im-
provements in viability, none of these studies evaluated
the functional capacity of their MSCs post-thaw, and it is
unclear whether a small change in viability would equate
to meaningful differences in functionality. These data are
particularly relevant to trials that employ allogeneic
MSCs. von Bahr et al. (2012) recently analyzed autopsy
tissues from 18 patients who had received allogeneic
MSC therapy, and demonstrated that infusion did not
result in ectopic tissue formation. In addition, PCR analysis
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be detected in patients early on, but with time, engraft-
ment became scarce. These data suggest that there is
limited long-term engraftment of allogeneic MSCs. It is
now well established that allogeneic MSCs do evoke an
immune response in vivo (Eliopoulos et al., 2005), and
this response can be classified as acute/innate (Crop et al.,
2011) or acquired (Eliopoulos et al., 2005; Poncelet
et al., 2007). In the case of an acute/innate effect, Moll
et al. (2012) demonstrated that allogeneic MSCs can evoke
an instant blood-mediated inflammatory reaction (IBMIR),
which can result in a rapid loss of up to 80% of the infused
cells, similar to what has been observed after allogeneic
hepatocyte transplantation (Gustafson et al., 2011).
Furthermore, Moll et al. (2014) recently demonstrated
that the IBMIR response to MSCs is intensified when cryo
MSCs are tested in vitro shortly after thawing. Whether
this IBMIR response occurs in both the allogeneic and
autologous MSC settings remains to be established; how-
ever, one would predict that regardless of the source of
the cells, the IBMIR response would likely be accentuated
immediately after thawing from cryopreservation. Thus,
to really optimize the cryopreservation and thawing pro-
cess of MSCs for therapeutic purposes, one must indepen-
dently evaluate the viability, functionality, and potential
immunogenicity (IBMIR) of these cells. Until such time as
a cryopreservation and thawing procedure can yield a
viable and fully functional MSC product immediately after
thawing, our data support the idea of using live MSCs
rather than post-thaw cryo MSCs for clinical evaluation
of MSCs as an immunosuppressive agent.EXPERIMENTAL PROCEDURES
MSC Isolation and Culture
hMSCs were isolated from bone marrow aspirates collected
from the iliac crest of consenting subjects (Emory University
IRB00046063) as previously described (Copland et al., 2013). After
the third passage, the MSC cultures were assayed by flow-cyto-
metric analysis for the absence of CD45+ and CD34+ contami-
nating cells and expression of CD44, CD73, CD90, and CD105
(BD Bioscience).
Cell Viability
Cell viability was evaluated using trypan blue exclusion and
Annexin V/PI or 7-AAD staining, and quantified by either standard
hemocytometry (trypanblue) or fluorescence-activated cell sorting
(FACS) analysis (Annexin V/PI or 7-AAD).
Cryopreservation and Thawing of MSCs
Subconfluent MSCs were trypsinized, washed, resuspended in
freezing media at a concentration of 5 3 106 cells/ml, and then
placed in a freezing container (Nalgene Mr. Frosty; Sigma). When
they reached 80C, the MSCs were transferred to liquid nitrogenfor cryostorage. For thawing, the MSCs were removed from the
liquid nitrogen, quickly thawed (1–2 min), and then immediately
transferred into MSC complete medium for centrifugation at
1,600 rpm for 5 min. The pelleted MSCs were resuspended in
MSC complete medium and recentrifuged prior to viability assess-
ment and enumeration.
Flow Cytometry
Annexin V/PI staining (Invitrogen) and calcium influx assay (Fluo-
4 NW calcium assay kit; Molecular Probes) were performed and
acquired via flow cytometry according to the manufacturers’ in-
structions. Cell-surface adhesion molecule profiling of MSCs was
performed with antibodies to CD63, CD51, HLA-ABC, CD29,
CD49d, CD41, CD54, CD61, and CD49e (Biolegend). All data
were collected on a BD FACSCanto II system (Becton Dickinson).
Cell-Binding Assay in the Static Condition
Live or cryo MSCs were labeled with the fluorescent dye
PKH26 (Sigma) and seeded onto fibronectin-coated plates at
5,000 cells/cm2. Two hours after seeding, the unbound cells were
removed from the plates and attached cells were imaged by epi-
fluorescence microscopy using an EVOS FL Cell Imaging System.
For quantitativemeasurements, the attached cells were trypsinized
and enumerated using either a hemocytometer or flow cytometry.
For flow-cytometry enumeration, pelleted cells from each condi-
tionwere resuspended in equivalent volumes and a BD FACSCanto
II (Becton Dickinson) was programmed to collect events for 60 s.
Based on the fluorescently gated cell population, the number of
events recorded correlated with the relative cell number. Relative
cell adherence was then expressed as a percentage, with live
MSCs counts normalized to 100%.
Microfluidics Flow System
The design and fabrication of three-dimensional in vitro ‘‘endothe-
lialized’’ microvasculature models were described previously (Tsai
et al., 2012). The microchannels were coated with 50 mg/ml fibro-
nectin from human plasma (Sigma) and then incubated at 37C,
5% CO2, for 1 hr. Endothelial cells were prepared at a concentra-
tion of 500,000 cells/ml in Endothelial Growth Medium-2
(EGM-2; Lonza) with 8% mass/vol of dextran 500 (Sigma). Endo-
thelial cells were manually preloaded into the inlet tubing and
infused into the channels with a syringe pump at 1.25 ml/min
for 2 hr, and then perfused with EGM-2 at the same rate for
2–3 days. Live or cryo MSCs were labeled with carboxyfluorescein
succinimidyl ester to render them fluorescent and then suspended
at 13 106 cells/ml in EGM-2. Following syringe loading, the MSCs
were pumped through the microchannels for 1 hr at 1.25 ml/min.
Epifluorescence and bright-field microscopy were acquired
following the experiment using an EVOS FL Cell Imaging System.
PrestoBlue Dye Reduction
Live or cryo MSCs were seeded onto a 96-well plate at the appro-
priate density. PrestoBlue cell viability reagent (Life Technologies)
was added, and at 3 hr postincubation the plates were read at
570 nm and 600 nm wavelengths to determine absorbance. The
percent reduction of PrestoBlue reagent was calculated according
to the manufacturer’s instructions.Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authors 69
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Animal experiments were carried out in accordance with the
guidelines an Institutional Animal Care and Use Committee. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Emory University. MSCs were prepared at a con-
centration of 13 106 total viable cells based on trypan blue exclu-
sion in infusion media (0.5% human albumin in PBS) and then
loaded into a syringe. C57BL/B6mice (8–10weeks old; The Jackson
Laboratories) were injected intravenously with MSCs via a tail
vein. The mice were euthanized in a CO2 chamber at the indicated
time points postinfusion to collect the specified organs. The
QIAamp DNA Mini Kit (QIAGEN) was used to extract DNA from
the tissues. Briefly, 25 mg of the organs was weighed and lysed
using a Proteinase K solution and then placed on QIAamp Mini
spin columns to extract gDNA according to the manufacturer’s
instruction. The extracted DNA was quantified using the Epoch
Micro-Volume Spectrophotometer System (Biotek) according to
the manufacturer’s protocol.
Quantitative Real-Time PCR
For gDNA PCR, 100 ng of total DNA was used as a template for
25 ml of reactionmix containing RT2 SYBR Green ROX qPCRmas-
ter mix (QIAGEN) and either the mouse RT2 qPCR primer gDNA
control primer set (QIAGEN), human SRY RT2 qPCR primer set
(QIAGEN), or the RT2 qPCR primer assay for human gDNA
contamination (Cat. No. PA-031; SA Biosciences). An Applied Bio-
system 7500 fast real-time PCR system was used to perform the
standard PCR cycle procedure to identify the CT values. The CT
values are expressed as an inverse (CT1) to better graphically
represent increases or decreases in expression.
Heat Killing and Cytochalasin D Treatment of MSCs
hMSCs (103 106) were resuspended in 0.5%human albumin (CSL
Behring LLC) in PBS at a concentration of 5 3 106 cells/ml. The
resuspended cells were placed on a 56C heating block for
30 min and then placed on ice before they were mixed with live
cells at a 1:1 ratio. Adherent MSCs were treated with Cytochalasin
D (Sigma) at a concentration of 2 mM for 2 hr at 37C in a 5% CO2
incubator. After incubation, the cells were washed in complete
medium and trypsinized. The cells were washed, counted, and
adjusted to a final concentration of 5 3 106 viable cells/ml in
0.5% human albumin in PBS.
F-Actin Staining
Fibronectin-coated coverslips were seeded with cryo, live, or Cyto-
chalasin D-treated MSCs at similar concentrations. At 2 hr postin-
cubation, unbound cells were washed away. The cells were fixed
with 10% formalin (Fisher Scientific) for 10 min. The fixed cells
were washed three times with PBS. F-actin and nuclei were stained
with phalloidin conjugated with Alexa 555 (Molecular Probes, In-
vitrogen) and DAPI (Molecular Probes, Invitrogen). The stained
cells were imaged with a Zeiss LSM 510 microscope. Images were
analyzed with the use of Zeiss ZEN 2009 software.
Statistical Analysis
Data were analyzed with GraphPad Prism 5.0 software. An un-
paired two-sided t test was used to determine significance between70 Stem Cell Reports j Vol. 3 j 60–72 j July 8, 2014 j ª2014 The Authorsthe means of two groups, and a one-way ANOVA with Tukey’s
multiple comparison test was used to compare multiple groups
simultaneously. A p value < 0.05 was considered statistically
significant.
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